Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
12 Feb 24 | KYTX Kyverna Therapeutics | Common Stock | Conversion | Acquire C | Yes | No | 0 | 735,984 | 0.00 | 735,984 |
12 Feb 24 | KYTX Kyverna Therapeutics | Common Stock | Conversion | Acquire C | Yes | No | 0 | 3,787,940 | 0.00 | 3,787,940 |
12 Feb 24 | KYTX Kyverna Therapeutics | Series B Redeemable Convertible Preferred Stock Common Stock | Conversion | Dispose C | Yes | No | 0 | 3,349,538 | 0.00 | 0 |
12 Feb 24 | KYTX Kyverna Therapeutics | Series B Redeemable Convertible Preferred Stock Common Stock | Conversion | Dispose C | Yes | No | 0 | 4,006,624 | 0.00 | 0 |
12 Feb 24 | KYTX Kyverna Therapeutics | Series A-2 Redeemable Convertible Preferred Stock Common Stock | Conversion | Dispose C | Yes | No | 0 | 8,830,901 | 0.00 | 0 |
12 Feb 24 | KYTX Kyverna Therapeutics | Series A-1 Redeemable Convertible Preferred Stock Common Stock | Conversion | Dispose C | Yes | No | 0 | 4,401,771 | 0.00 | 0 |